drugset / Trial / NCT01718119
Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of DA-3803(r-hCG) and Ovidrel for inducting final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment
Timeline
- Start
- 2012-02
- Primary completion
- 2013-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-3803 | Protein / enzyme biologic | 250 ug | Subcutaneous |